Imaging technology helps in scanning for retinal diseases
Advancements enable better diagnosis, treatment of patients.
New 2-year data supports faricimab-svoa for treatment of wet AMD
Presented during the 2022 ASRS meeting, results find that over 60% of participants could be treated every 4 months at 2 years—an increase from 45% at year 1.
Study confirms supplements slow AMD progression
A decade after the conclusion of the NIH-funded AREDS2 study, researchers found that the AREDS2 formula also reduces the risk of lung cancer.
Preparation is key to fighting dry eye while traveling
Best practices to help patients enjoy their trip to the fullest.
Dr. Coyne's #1 tip for managing dry eye
Alissa M. Coyne, OD, FAAO, FASOS, gives her number 1 tip for managing dry eye.
Q&A: What role does corneal hysteresis play in determining glaucoma risk?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.
Q&A: How is corneal hysteresis measured?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part two.
Bausch + Lomb, Novaliq submit NDA for NOV03 to treat DED associated with MGD
Drug submission of the first water-free therapy took place at the end of June, according to the companies.
Novartis acquires Kedalion Therapeutics and its ocular delivery platform
The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.
Interventional management of glaucoma offers big advantages
4 objectives are key for embracing a patient-focused form of care.
Q&A: What is corneal hysteresis?
Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.
Corneal hysteresis and biomechanics growing in diagnostic importance
Knowing your glaucoma vitals is key to providing best treatment for patients.
Dr. Casella's #1 tip for managing dry eye
Optometry Times'® Chief Optometric Editor Ben Casella, OD, FAAO, gives his number 1 tip for managing DED.
Poll: When do you feel it is time to discuss cataracts with your patients?
Dr. Koetting asks: When do you feel it is time to discuss cataracts with your patients?
Removing complex cataracts at advanced surgery center
The Medical University of South Carolina offers brand new, state-of-the-art surgery center dedicated solely to ophthalmic procedures.
LIGHTSITE III trial data shows vision improvement in intermediate dry AMD
Trial results demonstrated statistically significant improvement in the prespecified primary endpoint in BCVA at 13 months in the PBM treatment group over the sham-treatment group.
Advanced multi-purpose solution for soft re-usable contact lenses
Bausch + Lomb's Bill Reindel, OD, speaks on highlights from his lecture titled “Evaluation of an Advanced Multi-Purpose Solution for Soft Re-Usable Contact Lenses."
Presbyopia: Revolutionary research lines
Patients present with a plethora of complaints, with blurred near vision, headache, fatigue, need for increased working distance and brighter light to read among the most common, according to Cecelia Koetting, OD, during AOA 2022.
Cryosurgery: Available, efficient, and cost-effective for patients
Richard Castillo, OD, DO, shares his expertise in, "Cryosurgery for Optometric Surgeons: A safe, noninvasive, nonaerosolizing approach to periocular lesion removal in the COVID-19 era."
AMD: What to look for and how to deal with It
Elena Biffi, OD, MSc, FAAO, dives into AMD, a multifactorial disease that requires a multimodal diagnostic imaging approach.
